Corteva, Inc.

Valuation Analysis

About the Company

Corteva, Inc. operates in the agriculture business. The company operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics. This segment also provides digital solutions that assist farmer decision-making with a view to optimize product selection, and maximize yield and profitability. The Crop Protection segment offers products that protect against weeds, insects and other pests, and diseases, as well as enhances crop health above and below ground through nitrogen management and seed-applied technologies. This segment pro

Corteva, Inc. Stock at a Glance

Corteva, Inc. (CTVA) is currently trading at $76.14 with a market capitalization of $50.9B. The trailing P/E ratio stands at 41.16x, with a forward P/E of 18.56x. The 52-week range spans from $60.53 to $85.63; the current price is 11.1% below the yearly high. Year-over-year revenue growth stands at +11.0%. The net profit margin stands at 6.5%.

💰 Dividend

Corteva, Inc. pays an annual dividend of $0.72 per share, representing a yield of 0.95%. The payout ratio stands at 38.38%.

📊 Analyst Rating

21 analysts rate Corteva, Inc. (CTVA) on consensus: Buy. The average price target is $90.05, implying +18.27% from the current price. Analyst price targets range from $77.00 to $100.00.

Corteva, Inc.: The Investment Case in Detail

Corteva, Inc. (CTVA) operates in the Basic Materials — specifically Agricultural Inputs — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

The Bull Case

Revenue is growing at a healthy 11% pace year-over-year, suggesting the business model continues to find new customers and pricing power. The combination of a 48.56% gross margin and 23.69% operating margin shows the business converts revenue into profit efficiently — a hallmark of competitive moat. Wall Street consensus sits at Buy with an average price target implying roughly 18.27% upside from current levels — analyst sentiment is firmly constructive.

The Bear Case

Our valuation screen flags the stock as overvalued — current multiples imply the business needs to deliver well above its recent trajectory to justify the price.

Valuation in Context

The PEG ratio at 1.28 sits in the reasonable zone — the price tag is roughly aligned with the company's growth profile, neither punishing nor euphoric.

What to Watch Next

• The forward P/E of 18.56x is meaningfully below the trailing 41.16x — analysts expect earnings to step up; the next earnings release is the test.

Investment Thesis: Strengths & Weaknesses

Technical Snapshot

Price shows short-term weakness (below 50d MA) but is still in a longer-term uptrend (above 200d MA).

Risk Profile

The data points to relatively defensive market behavior.

Trading Data

💵 Dividend Info

Related Stocks in the Same Sector

Where can I buy Corteva, Inc.?

Compare top-rated brokers — low fees, trusted providers, fully regulated.